ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
| 第一著者: | |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
"Paediatrician" Publishers LLC
2008-08-01
|
| シリーズ: | Вопросы современной педиатрии |
| オンライン･アクセス: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Search Result 1